S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in
CNSX:PLUS

ePlus Competitors

Add
Compare
Today's Range N/A
50-Day Range
$0.57
MA: $0.74
$1.01
52-Week Range N/A
Volume20,900 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

ePlus (CNSX:PLUS) Vs. BUX, CHV, CSI, PHGI, PREV, and THCX

Should you be buying PLUS stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to ePlus, including (BUX) (BUX), (CHV) (CHV), (CSI) (CSI), (PHGI) (PHGI), (PREV) (PREV), and (THCX.V) (THCX).

ePlus (CNSX:PLUS) and (BUX) (CNSX:BUX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Earnings and Valuation

This table compares ePlus and (BUX)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ePlusN/AN/AN/AN/AN/A
(BUX)N/AN/AN/AN/AN/A

Profitability

This table compares ePlus and (BUX)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ePlusN/AN/AN/A
(BUX)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for ePlus and (BUX), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ePlus0000N/A
(BUX)0000N/A

ePlus (CNSX:PLUS) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Earnings and Valuation

This table compares ePlus and (CHV)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ePlusN/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

Profitability

This table compares ePlus and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ePlusN/AN/AN/A
(CHV)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for ePlus and (CHV), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ePlus0000N/A
(CHV)0000N/A

ePlus (CNSX:PLUS) and (CSI) (CNSX:CSI) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Earnings and Valuation

This table compares ePlus and (CSI)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ePlusN/AN/AN/AN/AN/A
(CSI)N/AN/AN/AN/AN/A

Profitability

This table compares ePlus and (CSI)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ePlusN/AN/AN/A
(CSI)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for ePlus and (CSI), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ePlus0000N/A
(CSI)0000N/A

ePlus (CNSX:PLUS) and (PHGI) (CNSX:PHGI) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Profitability

This table compares ePlus and (PHGI)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ePlusN/AN/AN/A
(PHGI)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for ePlus and (PHGI), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ePlus0000N/A
(PHGI)0000N/A

Earnings and Valuation

This table compares ePlus and (PHGI)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ePlusN/AN/AN/AN/AN/A
(PHGI)N/AN/AN/AN/AN/A

(PREV) (CNSX:PREV) and ePlus (CNSX:PLUS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares (PREV) and ePlus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
ePlusN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (PREV) and ePlus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
ePlus0000N/A

Valuation & Earnings

This table compares (PREV) and ePlus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
ePlusN/AN/AN/AN/AN/A

(THCX.V) (CVE:THCX) and ePlus (CNSX:PLUS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares (THCX.V) and ePlus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
ePlusN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (THCX.V) and ePlus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
ePlus0000N/A

Valuation & Earnings

This table compares (THCX.V) and ePlus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
ePlusN/AN/AN/AN/AN/A


ePlus Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
PHGI
(PHGI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00News Coverage
MYM
17031
0.4N/AN/AC$0.00N/A0.00
BAMM
28896
0.5N/AN/A$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
AGRA
Agraflora Organics International
1.4N/AN/A$0.00N/A0.00High Trading Volume
AMS
American Shared Hospital Services
0.6N/AN/A$0.00N/A0.00High Trading Volume
BE
Beleave
0.6N/AN/AC$0.00N/A0.00High Trading Volume
BE
Beleave
0.6N/AN/A$0.00N/A0.00High Trading Volume
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
CXV
BLVD Centers Co. (CXV.V)
0.5$0.07flatC$0.00N/A0.00Gap Down
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00Gap Up
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
DOC
CloudMD Software & Services
1.3$2.14flatC$0.00C$11.65 million-23.78Upcoming Earnings
High Trading Volume
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
EHC
Encompass Health
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
GRIN
Grindrod Shipping
1.7N/AN/A$0.00N/A0.00High Trading Volume
LTY
Liberty Biopharma
0.6$2.00flatC$0.00N/A-12.66Gap Down
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
LDS
Lifestyle Delivery Systems
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
ORTH
Ortho Regenerative Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49flatC$0.00N/A0.00High Trading Volume
Smith & Nephew logo
SNN
Smith & Nephew
0.6N/AN/A$0.00N/A0.00
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
SPR
Spirit AeroSystems
0.5N/AN/A$0.00N/A0.00High Trading Volume
THC
Tenet Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
THC
Tenet Healthcare
1.7N/AN/AC$0.00C$17.64 billion0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
VRS
Verisante Technology
0.5$0.02flatC$0.00N/A0.00Gap Down
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
VIDA
Vidaroo
0.5N/AN/A$0.00N/A0.00High Trading Volume
VMD
Viemed Healthcare
0.5$4.95flatC$0.00N/A0.00News Coverage
Gap Up
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.